Overview

Lilly's Emotional and Physical Symptoms of Depression Study (LEAPS)

Status:
Completed
Trial end date:
2005-01-01
Target enrollment:
Participant gender:
Summary
To assess the effectiveness of duloxetine administered once daily in patients with Major Depressive Disorder in a practice based setting
Phase:
Phase 4
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Duloxetine Hydrochloride